Pediatric psychopharmacology : principles and practice

Pediatric psychopharmacology principles and practice

This is a comprehensive text on the use of medication in the treatment of children and adolescents with serious neuropsychiatric disorders. It reconciles recent research findings with good clinical practice.

Detalles Bibliográficos
Otros Autores: Martin, Andres (-)
Formato: Libro electrónico
Idioma:Inglés
Publicado: Oxford ; New York : Oxford University Press c2003.
Edición:1st ed
Colección:Oxford scholarship online.
Materias:
Pediatric psychopharmacology.
Psychotropic drugs.
Ver en Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009798101406719
Tabla de Contenidos:
  • Contents; Contributors; SECTION I: BIOLOGICAL BASES OF PEDIATRIC PSYCHOPHARMACOLOGY; I-A: DEVELOPMENTAL PRINCIPLES OF NEUROBIOLOGY AND PSYCHOPHARMACOLOGY; 1. Overview of Brain Development; 2. Synaptic Function and Biochemical Neuroanatomy; 3. Mechanisms of Signal Transduction and Adaptation to Psychotropic Drug Action; 4. Pharmacokinetics I: Developmental Principles; 5. Pharmacokinetics II: Cytochrome P450-Mediated Drug Interactions; I-B: GENETIC PRINCIPLES; 6. Molecular Genetics; 7. Pharmacogenetics; I-C: DEVELOPMENTAL PSYCHOPATHOLOGY
  • 8. Neurobiology of Attention Regulation and its Disorders9. Neurobiology of Early-Life Stress and its Disorders; 10. Neurobiology of Early-Onset Mood Disorders; 11. Neurobiology of Early-Onset Anxiety Disorders; 12. Neurobiology of Obsessive-Compulsive Disorder; 13. Neurobiology of Tic Disorders, Including Tourette's Syndrome; 14. Neurobiology of Immune-Mediated Neuropsychiatric Disorders; 15. Neurobiology of Childhood Schizophrenia and Related Disorders; 16. Neurobiology of Affiliation: Implications for Autism Spectrum Disorders; 17. Neurobiology of Aggression
  • 18. Neurobiology of Eating Disorders19. Neurobiology of Substance Abuse and Dependence Disorders; SECTION II: SOMATIC INTERVENTIONS; II-A: PSYCHOTROPIC AGENTS; 20. Stimulants; 21. Adrenergic Agonists: Clonidine and Guanfacine; 22. Antidepressants I: Selective Serotonin Reuptake Inhibitors; 23. Antidepressants II: Tricyclic Agents; 24. Antidepressants III: Other Agents; 25. Mood Stabilizers: Lithium and Anticonvulsants; 26. Antipsychotic Agents: Traditional and Atypical; 27. Anxiolytics: Benzodiazepines, Buspirone, and Others; 28. Miscellaneous Compounds: Beta-Blockers and Opiate Antagonists
  • II-B: OTHER SOMATIC INTERVENTIONS29. Complementary and Alternative Medicine in Pediatric Psychopharmacology; 30. Electroconvulsive Therapy and Transcranial Magnetic Stimulation; SECTION III: ASSESSMENT AND TREATMENT; III-A: GENERAL PRINCIPLES; 31. Clinical Assessment of Children and Adolescents Treated Pharmacologically; 32. Clinical Instruments and Scales in Pediatric Psychopharmacology; 33. Thinking About Prescribing: The Psychology of Psychopharmacology; 34. Combining Pharmacotherapy and Psychotherapy: An Evidence-Based Approach; III-B: SPECIFIC DISORDERS AND SYNDROMES
  • 35. Attention-Deficit Hyperactivity Disorder36. Depressive Disorders; 37. Bipolar Disorder; 38. Anxiety Disorders; 39. Obsessive-Compulsive Disorder; 40. Tourette's Syndrome and Other Tic Disorders; 41. Early-Onset Schizophrenia; 42. Autistic and Other Pervasive Developmental Disorders; 43. Post-traumatic Stress Disorder; 44. Eating Disorders; III-C: SPECIAL CLINICAL POPULATIONS; 45. Substance-Abusing Youths; 46. Individuals with Mental Retardation; 47. The Medically Ill Child or Adolescent; 48. Psychopharmacology During Pregnancy: Infant Considerations
  • 49. Psychopharmacological Treatment of Preschoolers

Ejemplares similares